SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001016169-11-000003
Filing Date
2011-03-14
Accepted
2011-03-14 17:06:26
Documents
11
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 k10-dec2010.htm 10-K 1606674
2 injection2010.jpg GRAPHIC 102897
3 transdermal2010.jpg GRAPHIC 74658
4 k10-dec20100.jpg GRAPHIC 51605
5 exhibit1020.htm EX-10.20 53009
6 exhibit211.htm EX-21.1 7996
7 exhibit231.htm EX-23.1 6864
8 exhibit311.htm EX-31.1 14755
9 exhibit312.htm EX-31.2 14825
10 exhibit321.htm EX-32.1 8557
11 exhibit322.htm EX-32.2 8567
  Complete submission text file 0001016169-11-000003.txt   2038675
Mailing Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618
Business Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
Type: 10-K | Act: 34 | File No.: 001-32302 | Film No.: 11686211
SIC: 3841 Surgical & Medical Instruments & Apparatus
Office of Life Sciences